A borderline range for Quantiferon Gold In-Tube results

PLoS ONE

Volumn 12, Issue 11, 2017, Pages

  Jonsson, Jerker ^a,b   Westman, Anna ^c,d   Bruchfeld, Judith ^b,d   Sturegård, Erik ^e   Gaines, Hans ^a,b,d   Schön, Thomas ^f,g  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e LUND UNIVERSITY   (Sweden)

^f KALMAR COUNTY HOSPITAL   (Sweden)

^g LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; FOLLOW UP; HUMAN; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; QUALITATIVE VALIDITY; QUALITY CONTROL; REFERENCE VALUE; RISK ASSESSMENT; TEST RETEST RELIABILITY; TUBERCULOSIS; BLOOD; LATENT TUBERCULOSIS; REPRODUCIBILITY; SWEDEN;

GAMMA INTERFERON;

HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SWEDEN;

EID: 85033400898     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0187313     Document Type: Article

References (25)

1. O’Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annual review of immunology. 2013; 31:475–527. Epub 2013/03/23. https://doi.org/10.1146/annurev-immunol-032712-095939 PMID: 23516984.
2. Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-gamma release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest. 2012; 142(1):63–75. Epub 2012/04/12. https://doi.org/10.1378/chest.11-3157 PMID: 22490872.
3. Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, Mwansa-Kambafwile J, et al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. The Lancet Infectious diseases. 2012; 12(1):45–55. Epub 2011/08/19. https://doi.org/10.1016/S1473-3099(11)70210-9 PMID: 21846592
4. Welfare TSNBfHa. National Swedish recommendations on preventive measures against tuberculosis. 2013.
5. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection—United States, 2010. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. 2010; 59(RR-5):1–25. Epub 2010/06/26. PMID: 20577159.
6. Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, et al. Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. American journal of respiratory and critical care medicine. 2014; 189 (1):77–87. Epub 2013/12/05. https://doi.org/10.1164/rccm.201302-0365OC PMID: 24299555.
7. Moses MW, Zwerling A, Cattamanchi A, Denkinger CM, Banaei N, Kik SV, et al. Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model. Scientific reports. 2016; 6:30781. Epub 2016/07/30. https://doi.org/10.1038/srep30781 PMID: 27469388
8. Joshi M, Monson TP, Joshi A, Woods GL. IFN-gamma release assay conversions and reversions. Challenges with serial testing in U.S. health care workers. Annals of the American Thoracic Society. 2014; 11(3):296–302. Epub 2014/01/23. https://doi.org/10.1513/AnnalsATS.201310-378OC PMID: 24446969.
9. Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2016. Epub 2016/12/10. https://doi.org/10.1093/cid/ciw694 PMID: 27932390.
10. Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, Ha NP, Graviss EA. Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. American journal of respiratory and critical care medicine. 2013; 187(2):206–11. Epub 2012/10/30. https://doi.org/10.1164/rccm.201203-0430OC PMID: 23103734
11. Nienhaus A, Schablon A, Preisser AM, Ringshausen FC, Diel R. Tuberculosis in healthcare workers—a narrative review from a German perspective. J Occup Med Toxicol. 2014; 9(1):9. Epub 2014/03/15. https://doi.org/10.1186/1745-6673-9-9 PMID: 24625063
12. Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clinical microbiology reviews. 2014; 27 (1):3–20. Epub 2014/01/08. https://doi.org/10.1128/CMR.00034-13 PMID: 24396134
13. Schablon A, Nienhaus A, Ringshausen FC, Preisser AM, Peters C. Occupational screening for tuberculosis and the use of a borderline zone for interpretation of the IGRA in German healthcare workers. PloS one. 2014; 9(12):e115322. Epub 2014/12/30. https://doi.org/10.1371/journal.pone.0115322 PMID: 25541947
14. Simpson T, Fox J, Crouse K, Field K. Quantitative and qualitative QuantiFERON((R))-TB gold in-tube results among groups with varying risks of exposure to tuberculosis. Heart & lung: the journal of critical care. 2012; 41(6):553–61. Epub 2012/07/31. https://doi.org/10.1016/j.hrtlng.2012.06.005 PMID: 22840377.
15. Tagmouti S, Slater M, Benedetti A, Kik SV, Banaei N, Cattamanchi A, et al. Reproducibility of interferon gamma (IFN-gamma) release Assays. A systematic review. Annals of the American Thoracic Society. 2014; 11(8):1267–76. Epub 2014/09/05. https://doi.org/10.1513/AnnalsATS.201405-188OC PMID: 25188809.
16. Gamsky TE, Lum T, Hung-Fan M, Green JA. Cumulative False-Positive QuantiFERON-TB Interferon-gamma Release Assay Results. Annals of the American Thoracic Society. 2016; 13(5):660–5. Epub 2016/01/20. https://doi.org/10.1513/AnnalsATS.201508-532OC PMID: 26783649.
17. Getahun H, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis Infection. The New England journal of medicine. 2015; 373(12):1179–80. Epub 2015/09/17. https://doi.org/10.1056/NEJMc1508223 PMID: 26376149.
18. Banaei N, Gaur RL, Pai M. Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability? Journal of clinical microbiology. 2016; 54(4):845–50. Epub 2016/01/15. https://doi.org/10.1128/JCM.02803-15 PMID: 26763969
19. Thanassi W, Noda A, Hernandez B, Friedman L, Dorman S, Yesavage J. Negative Tuberculin Skin Test and Prediction of Reversion of QuantiFERON Interferon Gamma Release Assay in US Healthcare Workers. Infection control and hospital epidemiology. 2016; 37(4):478–82. Epub 2016/01/29. https://doi.org/10.1017/ice.2015.324 PMID: 26818401.
20. Public Health Agency of Sweden. 2015.; https://www.folkhalsomyndigheten.se/folkhalsorapporteringstatistik/statistikdatabaser-och-visualisering/sjukdomsstatistik/tuberkulos/?t=com&p=18610 last accessed 12th of december 2016.
21. Hermansen TS, Lillebaek T, Langholz Kristensen K, Andersen PH, Ravn P. Prognostic value of interferon-gamma release assays, a population-based study from a TB low-incidence country. Thorax. 2016; 71(7):652–8. Epub 2016/04/01. https://doi.org/10.1136/thoraxjnl-2015-208228 PMID: 27030576.
22. Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, et al. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening. The European respiratory journal. 2016; 48 (5):1411–9. Epub 2016/11/02. https://doi.org/10.1183/13993003.00510-2016 PMID: 27390280.
23. Hoffmann H, Avsar K, Gores R, Mavi SC, Hofmann-Thiel S. Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2016; 22(8):701–3. Epub 2016/05/18. https://doi.org/10.1016/j. cmi.2016.05.006 PMID: 27184875.
24. Yi L, Sasaki Y, Nagai H, Ishikawa S, Takamori M, Sakashita K, et al. Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan. Scientific reports. 2016; 6:30617. Epub 2016/07/30. https://doi.org/10.1038/srep30617 PMID: 27470684
25. Knierer J, Gallegos Morales EN, Schablon A, Nienhaus A, Kersten JF. QFT-Plus: a plus in variability? —Evaluation of new generation IGRA in serial testing of students with a migration background in Germany. J Occup Med Toxicol. 2017; 12:1. Epub 2017/01/11. https://doi.org/10.1186/s12995-016-0148-z PMID: 28070206